norgestimate has been researched along with Endometrial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Back, DJ; Rudland, PS; Wild, MJ | 1 |
| Rozenberg, S | 1 |
1 review(s) available for norgestimate and Endometrial Neoplasms
| Article | Year |
|---|---|
Clinical evidence supporting the rationale for constant oestrogen, intermittent progestogen hormone replacement therapy.
Topics: Animals; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Hormone Replacement Therapy; Humans; Menopause; Norgestrel; Progestins; Risk Factors | 2001 |
1 other study(ies) available for norgestimate and Endometrial Neoplasms
| Article | Year |
|---|---|
Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Desogestrel; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Tumor Cells, Cultured | 1993 |